Asthma/Steroid Withdrawal Study

PHASE4TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Asthma
Interventions
DRUG

inhaled corticosteroid

Fluticasone; Budesonide; Ciclesonide Dosage and frequency is patient dependant.

Trial Locations (1)

T6G 2B7

University of Alberta Hospital, Edmonton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Alberta

OTHER

NCT00395239 - Asthma/Steroid Withdrawal Study | Biotech Hunter | Biotech Hunter